ABSTRACT
In the United States, 750,000 people are diagnosed with sepsis every year (Bansal et al., 2018), accounting for 250,000 deaths (Harrison et al., 2015) and 51% of total ICU admissions (Bansal et al., 2018). Sepsis is a complex disease with an even more complex management and treatment process. Diagnosis of sepsis consists of suspected or proven infection and systemic inflammatory response syndrome (SIRS). Delay in diagnosis places a burden on the healthcare system, costing close to 15.4 billion dollars annually 286(Bansal et al., 2018). Advanced detection can help mitigate these challenges by allowing for earlier diagnosis (Harrison et al., 2015). Furthermore, initiating early treatment would have a significant impact on mortality rates and alleviate the strain on healthcare resources allocated to sepsis treatment (Bansal et al., 2018).
